Croda strengthens position in Health Care with the acquisition of Avanti Polar Lipids
Croda International Plc (‘Croda’) announces that it has agreed to acquire Avanti Polar Lipids, Inc. (‘Avanti’), a knowledge-intensive leader in lipid-based drug delivery technologies for next generation pharmaceuticals.
Croda working with partners on development of Covid-19 vaccination
During the emergence of the pandemic, Croda has actively reached out to research groups around the world, offering free of charge material and expertise.
Super Refined™ Excipients
The highest and purest grades of excipients to help you formulate seamlessly and drive your drug products to market.
Our high purity pharmaceutical excipients, in-house formulation expertise, strong analytical capability and vaccine adjuvants portfolio make us the ideal solutions provider with whom to navigate drug and vaccine formulation challenges.
Discover what makes us a top choice for global pharmaceutical and vaccine formulators.